(PharmaNewsWire.Com, February 26, 2018 ) The Asia Pacific Protein Therapeutics market size was around USD 28.2 billion in 2017. It is expected to grow at a CAGR of 7.3% to reach USD 40.11 billion by 2022. It captures 20% of the global market.
Protein therapeutics is most often employed in the treatment of chronic ailments like cancer etc. This market has a huge potential in the coming years.
Increasing number of people suffering from chronic diseases coupled with rapid advancements in the medical sciences resulting in the development of plasma based therapies are driving the growth of this market. On the other hand, vague government policies and cumbersome administrative framework conjoined with the heavy cost of this treatment are inhibiting market growth.
The market has been segregated into three categories namely - by product, by application and by therapeutic modalities. Classification by product entails Interferon, Human Growth Hormone, Insulin, Fusion Protein, Follicle Stimulating Hormone, and Monoclonal Antibodies, Erythropoietin. In 2016, Monoclonal antibodies captured the largest market share. It is projected to remain the top leading segment in the forecast period. It is also the market sub-segment which is anticipated to undergo fastest growth till 2022. Classification by application entails Cancer, Hormonal Disorders, Immunologic Disorders, Haematological Disorders, Metabolic Disorders, Genetic Disorders, and Others. In 2016, metabolic disorders accounted for the highest market share. However, cancer market sub-category is predicted to grow the fastest in the forecast period. Classification by therapeutic modalities entails Protein therapeutics with special targeting activity, Protein diagnostics, Protein vaccines, and Protein therapeutics with enzymatic or regulatory activity.
Classification by geography entails India, China, Korea, Japan and others. However, growing awareness about these novel treatment methods in the emerging economies makes it likely that Asia Pacific will grow with the highest CAGR in the forecast period. China leads the market in this region. Key players in the market are Baxter International Inc., Eli Lilly and Company, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche Ltd. Other players in the market are Novo Nordisk A/S, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., and Sanofi.
Market Segmentation: 1) Product Introduction Monoclonal Antibodies Insulin Fusion Protein Erythropoietin Interferon Human Growth Hormone Follicle Stimulating Hormone
2) Therapeutic Modalities Introduction Protein diagnostics Protein vaccines Protein therapeutics with special targeting activity Protein therapeutics with enzymatic or regulatory activity
Scope of the Report: Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
